EED226-COOH is primarily utilized in the field of medicinal chemistry and drug development. It serves as a key intermediate in the synthesis of small molecule inhibitors, particularly those targeting specific protein-protein interactions or enzymatic activities. Its carboxylic acid group allows for further functionalization, making it a versatile building block in the design of potential therapeutic agents. Researchers often employ it in the development of compounds aimed at treating diseases such as cancer, where modulation of specific biological pathways is crucial. Additionally, its structural features make it suitable for use in high-throughput screening assays to identify novel drug candidates.